Satoru Saito

10.4k total citations · 1 hit paper
221 papers, 6.8k citations indexed

About

Satoru Saito is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Satoru Saito has authored 221 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Epidemiology, 88 papers in Hepatology and 62 papers in Surgery. Recurrent topics in Satoru Saito's work include Liver Disease Diagnosis and Treatment (113 papers), Liver Disease and Transplantation (36 papers) and Diet, Metabolism, and Disease (26 papers). Satoru Saito is often cited by papers focused on Liver Disease Diagnosis and Treatment (113 papers), Liver Disease and Transplantation (36 papers) and Diet, Metabolism, and Disease (26 papers). Satoru Saito collaborates with scholars based in Japan, United States and United Kingdom. Satoru Saito's co-authors include Atsushi Nakajima, Masato Yoneda, Koji Fujita, Hiroyuki Kirikoshi, Kento Imajo, Yuji Ogawa, Masahiko Inamori, Yuichi Nozaki, Hironori Mawatari and Yasushi Honda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Gastroenterology.

In The Last Decade

Satoru Saito

210 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

2015 598 citations Kento Imajo, Takaomi Kessoku et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoru Saito Japan	42	4.6k	2.5k	1.5k	1.4k	1.0k	221	6.8k
Makoto Nakamuta Japan	42	3.6k 0.8×	2.2k 0.9×	1.3k 0.9×	1.2k 0.8×	1.9k 1.8×	217	6.6k
Henning Grønbæk Denmark	43	5.2k 1.1×	2.3k 0.9×	1.6k 1.0×	1.4k 1.0×	1.3k 1.3×	329	8.4k
Jérôme Boursier France	43	6.5k 1.4×	4.0k 1.6×	1.1k 0.8×	1.6k 1.1×	1.4k 1.4×	187	8.1k
Koji Fujita Japan	43	3.9k 0.9×	2.0k 0.8×	1.3k 0.9×	1.4k 1.0×	3.2k 3.2×	285	8.9k
Cynthia D. Guy United States	38	5.5k 1.2×	2.3k 0.9×	1.2k 0.8×	2.2k 1.6×	2.1k 2.1×	104	7.7k
Prithi S. Bhathal Australia	35	3.1k 0.7×	1.6k 0.6×	1.7k 1.1×	1.2k 0.8×	1.0k 1.0×	122	6.1k
Yoichi Hiasa Japan	43	4.2k 0.9×	3.9k 1.6×	1.2k 0.8×	755 0.5×	765 0.8×	406	7.2k
Hirokazu Takahashi Japan	46	3.1k 0.7×	1.2k 0.5×	1.3k 0.9×	1.3k 0.9×	2.0k 2.0×	219	6.9k
Masato Yoneda Japan	54	7.0k 1.5×	3.2k 1.3×	2.8k 1.8×	2.7k 1.9×	1.8k 1.8×	309	11.4k
Morikazu Onji Japan	47	4.0k 0.9×	3.6k 1.5×	1.1k 0.7×	593 0.4×	761 0.7×	313	7.3k

Countries citing papers authored by Satoru Saito

Since Specialization

Citations

This map shows the geographic impact of Satoru Saito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Saito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Saito more than expected).

Fields of papers citing papers by Satoru Saito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoru Saito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Saito. The network helps show where Satoru Saito may publish in the future.

Co-authorship network of co-authors of Satoru Saito

This figure shows the co-authorship network connecting the top 25 collaborators of Satoru Saito. A scholar is included among the top collaborators of Satoru Saito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoru Saito. Satoru Saito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koyama, Shingo, Asako Nogami, Masato Yoneda, et al.. (2024). Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis. Tomography. 10(4). 471–479. 1 indexed citations

Iwaki, Michihiro, Masato Yoneda, Naohiro Wada, et al.. (2024). Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitis. Expert Opinion on Emerging Drugs. 29(2). 127–137. 1 indexed citations

Iwaki, Michihiro, Takashi Kobayashi, Asako Nogami, et al.. (2023). Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease. Nutrients. 15(4). 891–891. 34 indexed citations

Kobayashi, Takashi, Michihiro Iwaki, Asako Nogami, et al.. (2023). Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review. Nutrients. 15(5). 1269–1269. 4 indexed citations

Yoneda, Masato, Takashi Kobayashi, Michihiro Iwaki, et al.. (2023). Nonalcoholic Fatty Liver Disease as a Systemic Disease and the Need for Multidisciplinary Care. Gut and Liver. 17(6). 843–852. 5 indexed citations

Iwaki, Michihiro, et al.. (2023). Frontiers of Collaboration between Primary Care and Specialists in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review. Life. 13(11). 2144–2144. 7 indexed citations

Kobayashi, Takashi, Michihiro Iwaki, Asako Nogami, et al.. (2023). Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography. Journal of Gastroenterology. 59(1). 56–65. 9 indexed citations

Nogami, Asako, Michihiro Iwaki, Takashi Kobayashi, et al.. (2022). Real‐world assessment of SmartExam, a novel FibroScan computational method: A retrospective single‐center cohort study. Journal of Gastroenterology and Hepatology. 38(2). 321–329. 7 indexed citations

Iwaki, Michihiro, Takaomi Kessoku, Kosuke Tanaka, et al.. (2022). Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study. BMJ Open. 12(7). e060335–e060335. 2 indexed citations

10.

Iwaki, Michihiro, Takaomi Kessoku, Kosuke Tanaka, et al.. (2022). Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease. JGH Open. 6(10). 696–703. 5 indexed citations

11.

Yoneda, Masato, Yasushi Honda, Yuji Ogawa, et al.. (2021). Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): a randomized prospective open-label controlled trial. BMJ Open Diabetes Research & Care. 9(1). e001990–e001990. 78 indexed citations

12.

Watanabe, Tomoya, Naoko Takamura, Yuko Watanabe, et al.. (2021). A pediatric case of Stevens‐Johnson syndrome with acute liver failure, resulting in liver transplantation. The Journal of Dermatology. 48(9). 1423–1427. 3 indexed citations

13.

Kessoku, Takaomi, Takashi Kobayashi, Anna Ozaki, et al.. (2020). Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease. BMJ Open. 10(9). e037961–e037961. 8 indexed citations

14.

Kasagi, Yuta, Yui Harada, Yosuke Morodomi, et al.. (2016). Peritoneal Dissemination Requires an Sp1-Dependent CXCR4/CXCL12 Signaling Axis and Extracellular Matrix–Directed Spheroid Formation. Cancer Research. 76(2). 347–357. 26 indexed citations

15.

Iida, Hiroshi, Masahiko Inamori, Yusuke Sekino, et al.. (2015). Early effects of oral administration of esomeprazole and omeprazole on the intragastric pH.. PubMed. 62(138). 493–6. 2 indexed citations

16.

Ogawa, Yuji, Masato Yoneda, Wataru Tomeno, et al.. (2012). Peroxisome Proliferator-Activated Receptor Gamma Exacerbates Concanavalin A-Induced Liver Injury via Suppressing the Translocation of NF-κB into the Nucleus. PPAR Research. 2012. 1–5. 11 indexed citations

17.

Iida, Hiroshi, et al.. (2008). A case of autoimmune pancreatitis developed pancreatic tail cancer. Suizo. 23(5). 608–614. 11 indexed citations

18.

Fujita, Koji, Yuichi Nozaki, Koichiro Wada, et al.. (2008). Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. Gut. 57(11). 1583–1591. 106 indexed citations

19.

Fujisawa, Toshio, Hideki Endo, Ayako Tomimoto, et al.. (2008). Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut. 57(11). 1531–1538. 151 indexed citations

20.

Tomimoto, Ayako, Koichiro Wada, Toshio Fujisawa, et al.. (2007). 5-Aminosalicylic Acid Given in the Remission Stage of Colitis Suppresses Colitis-Associated Cancer in a Mouse Colitis Model. Clinical Cancer Research. 13(21). 6527–6531. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact